MedPath

Longterm Follow-up After Remote Ischemic Preconditioning for Prevention of Contrast-induced Nephropathy

Conditions
Impaired Renal Function
Interventions
Other: Ischemic preconditioning
Registration Number
NCT01760031
Lead Sponsor
University of Cologne
Brief Summary

Remote ischemic preconditioning reduces the incidence of contrast-induced acute kidney injury in patients undergoing elective coronary angiography. This study was designed to acquire long-term data of initially randomized patients in the RenPro Trial.

Detailed Description

Data of the RenPro Trial has been already published. In the present study data of longterm follow up are collected.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
81
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Subjects with impaired renal functionIschemic preconditioningSubjects with baseline impaired renal function undergoing cardiac catheterization with contrast-medium exposure
Primary Outcome Measures
NameTimeMethod
MACCE1 Year

Major Adverse Cardiac and Cerebrovascular Events (Combined primary endpoint):

All-cause mortality, cardiovascular mortality, rehospitalization, stroke, myocardial infarction, hemodialysis

Secondary Outcome Measures
NameTimeMethod
Renal function1 year

changes of serum creatinine, eGFR, NGAL and cystatin C compared to baseline in both groups.

Trial Locations

Locations (1)

University of Cologne

🇩🇪

Cologne, NRW, Germany

© Copyright 2025. All Rights Reserved by MedPath